Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Curved path walking reveals subtle gait impairments linked to cognitive decline

Curved path walking reveals subtle gait impairments linked to cognitive decline

Boosting curcumin's absorption and effectiveness for disease prevention and therapy

Boosting curcumin's absorption and effectiveness for disease prevention and therapy

Wristwatch-like devices detect early signs of Alzheimer's

Wristwatch-like devices detect early signs of Alzheimer's

Nutrition's crucial role in Alzheimer's progression revealed

Nutrition's crucial role in Alzheimer's progression revealed

Stroke risk linked to sleep apnea may vary for Black people and white people

Stroke risk linked to sleep apnea may vary for Black people and white people

Essential tremor associated with increased risk of dementia

Essential tremor associated with increased risk of dementia

The Brain Prize 2024 recognizes pioneering work in computational and theoretical neuroscience

The Brain Prize 2024 recognizes pioneering work in computational and theoretical neuroscience

Study reveals surge of a neural-specific protein as the earliest-yet biomarker for Alzheimer's disease

Study reveals surge of a neural-specific protein as the earliest-yet biomarker for Alzheimer's disease

Noninvasive gamma therapy may hold promise for treating chemo brain

Noninvasive gamma therapy may hold promise for treating chemo brain

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

Study reveals safety of MS drugs during breastfeeding in child's early years of life

Study reveals safety of MS drugs during breastfeeding in child's early years of life

People with sleep apnea more likely to have memory or thinking problems

People with sleep apnea more likely to have memory or thinking problems

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

Poor spatial orientation contributes to driving risks for older drivers

Poor spatial orientation contributes to driving risks for older drivers

Association of volatile aromatic compounds in blood with hearing impairment

Association of volatile aromatic compounds in blood with hearing impairment

Impaired spatial navigation signals early Alzheimer's risk

Impaired spatial navigation signals early Alzheimer's risk

Tandem cycling boosts well-being for Parkinson's patients and care partners

Tandem cycling boosts well-being for Parkinson's patients and care partners

Understanding language deterioration in amnestic mild cognitive impairment

Understanding language deterioration in amnestic mild cognitive impairment

Study links magnetite particle exposure to Alzheimer's disease symptoms

Study links magnetite particle exposure to Alzheimer's disease symptoms

Rare gene mutations in hereditary Alzheimer's disease disrupt amyloid production, study shows

Rare gene mutations in hereditary Alzheimer's disease disrupt amyloid production, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.